Brevenair was founded by Dan, after his UNCW retirement in 2019. He is internationally recognized for his R&D of the biopharmaceuticals produced by Karenia brevis. His work includes 16 new bioactives, RIA, ELISA, antibodies, receptor binding assays,..
Relevance: 17.789017